Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

This page shows the publications co-authored by Marcelo Di Carli and Rodney Falk.
Connection Strength

1.106
  1. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
    View in: PubMed
    Score: 0.233
  2. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67.
    View in: PubMed
    Score: 0.152
  3. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62.
    View in: PubMed
    Score: 0.151
  4. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11.
    View in: PubMed
    Score: 0.058
  5. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.057
  6. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.
    View in: PubMed
    Score: 0.055
  7. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT. J Nucl Cardiol. 2019 Nov 22.
    View in: PubMed
    Score: 0.055
  8. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019 06; 12(6):e005407.
    View in: PubMed
    Score: 0.053
  9. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.
    View in: PubMed
    Score: 0.053
  10. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019 02; 26(1):158-173.
    View in: PubMed
    Score: 0.052
  11. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018 09 01; 3(9):865-870.
    View in: PubMed
    Score: 0.051
  12. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.050
  13. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3.
    View in: PubMed
    Score: 0.045
  14. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8).
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.